Literature DB >> 18326524

Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics.

Karin Bink1, Eugenia Haralambieva, Marcus Kremer, German Ott, Christine Beham-Schmid, Laurence de Leval, Suat Cheng Peh, Hubert R Laeng, Uta Jütting, Peter Hutzler, Leticia Quintanilla-Martinez, Falko Fend.   

Abstract

Primary extramedullary plasmacytoma is an indolent neoplasm that infrequently converts to multiple myeloma. Since cytogenetic data on extramedullary plasmacytoma are lacking, we studied 38 cases of this type of neoplasm by fluorescence in situ hybridization. Fourteen cases (37%) contained IGH breaks, including six with a t(4;14) translocation. No translocations t(11;14), t(14;16), t(8;14), nor breaks involving MALT1, BCL6 or FOXP1 were found. Loss of 13q (40%), as well as chromosomal gains (82%) were common. There was no correlation between chromosomal alterations and clinical features or local relapse. Cytogenetically, extramedullary plasmacytoma and multiple myeloma are closely related. However, the distribution of IGH translocation partners, with the notable absence of t(11;14), is different. Key words: extramedullary plasmacytoma, multiple myeloma, cytogenetics, IGH translocation, fluorescence in situ hybridization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326524     DOI: 10.3324/haematol.12005

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  25 in total

1.  EBV-positive plasmacytoma of the submandibular gland--report of a rare case with molecular genetic characterization.

Authors:  Benedict Yan; Soo Yong Tan; Ee Xuan Yau; Siok Bian Ng; Fredrik Petersson
Journal:  Head Neck Pathol       Date:  2011-03-26

Review 2.  Expect the Unexpected: Report of a Case of Pediatric Pharyngeal Extraosseous Plasmacytoma with Tumefactive Amyloidosis ("Amyloidoma") and a Review of the Literature.

Authors:  Char Loo Tan; Sze Hwa Tan; Siok Bian Ng; Fredrik Petersson
Journal:  Head Neck Pathol       Date:  2015-02-12

3.  Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myeloma.

Authors:  Chee Man Cheong; Krzysztof M Mrozik; Duncan R Hewett; Elyse Bell; Vasilios Panagopoulos; Jacqueline E Noll; Jonathan D Licht; Stan Gronthos; Andrew C W Zannettino; Kate Vandyke
Journal:  Cancer Lett       Date:  2020-01-31       Impact factor: 8.679

4.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours.

Authors:  Noah A Brown; Kojo S J Elenitoba-Johnson
Journal:  Head Neck Pathol       Date:  2017-02-28

5.  The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model.

Authors:  Shyril O'Steen; Melissa L Comstock; Johnnie J Orozco; Donald K Hamlin; D Scott Wilbur; Jon C Jones; Aimee Kenoyer; Margaret E Nartea; Yukang Lin; Brian W Miller; Theodore A Gooley; Sherilyn A Tuazon; Brian G Till; Ajay K Gopal; Brenda M Sandmaier; Oliver W Press; Damian J Green
Journal:  Blood       Date:  2019-10-10       Impact factor: 22.113

6.  IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.

Authors:  Alexandra Valera; Olga Balagué; Luis Colomo; Antonio Martínez; Jan Delabie; Lekidelu Taddesse-Heath; Elaine S Jaffe; Elías Campo
Journal:  Am J Surg Pathol       Date:  2010-11       Impact factor: 6.394

Review 7.  [Molecular pathology of plasma cell neoplasms].

Authors:  F Fend
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

8.  Extramedullary plasmacytoma of the trachea.

Authors:  Renu Sukumaran; Rekha A Nair; Priya Mary Jacob; Sumod Mathew Koshy; Arun Peter Mathew
Journal:  Head Neck Pathol       Date:  2013-09-18

Review 9.  Targeted therapy in rare cancers--adopting the orphans.

Authors:  Javier Munoz; Razelle Kurzrock
Journal:  Nat Rev Clin Oncol       Date:  2012-09-11       Impact factor: 66.675

10.  CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies.

Authors:  Damian J Green; Shyril O'Steen; Yukang Lin; Melissa L Comstock; Aimee L Kenoyer; Donald K Hamlin; D Scott Wilbur; Darrell R Fisher; Margaret Nartea; Mark D Hylarides; Ajay K Gopal; Theodore A Gooley; Johnnie J Orozco; Brian G Till; Kelly D Orcutt; K Dane Wittrup; Oliver W Press
Journal:  Blood       Date:  2017-11-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.